Investors' Chronicle

Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions. Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Our

Investors' Chronicle is a business podcast hosted by Unknown Host, with 1,000 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Investors' Chronicle, a business show with 1,000 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Investors' Chronicle

  Legal & General, infrastructure stocks and GSK:Companies and Markets Show

  Aug 13, 202626 min

  After an avalanche of earnings updates, we turn to our annual Income Majors special report and dive into two prominent FTSE 100 dividend stocks. First up is insurer Legal & General; pressure has been mounting on the company as it grapples with a more competitive pensions market. Christopher Akers explains the CEO’s buyback plan, its yield and what it means for investors. We then move to GSK, once known as GlaxoSmithKline, which faces a tricky balancing act between dividends and developing new drugs. The pharma giant has been spending heavily on R&D – a staggering £18bn this year alone to build its oncology pipeline. Julian Hofmann has the details. Finally, we cast our ears to Hill & Smith’s growth across the pond. The steel products company now generates two-thirds of its revenue from the US and has even switched its currency from sterling to dollars. Michael Fahy discusses what’s going on at the growing business. Timestamps: 00:00 Intro 03:22  Legal & General 10:42 GSK 18:57 Hill & Smith Listen to more podcasts from Investors’ Chronicle on Apple , Spotify and YouTube Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times . Hosted on Acast. See acast.com/privacy for more information.

  ListenShow Notes
• 

  Investors' Chronicle

  How to defeat the gender wealth gap

  Aug 10, 202628 min

  Women, on average, earn less than men, have less saved in a pension and have to take more time off from work to care for others. But while society is rigged to burden women with heavier loads, Gina Miller has made it her mission to change this and close the gender wealth gap.  Gina is an activist, entrepreneur and the founder of MoneyShe, an investment platform focused on women’s finances. Gina, who became widely known for her anti-Brexit campaign and has spent decades working in the City, sits down with funds editor Val Cipriani to discuss the barriers blocking women from investing, the inherent misogyny in finance and practical steps to build a portfolio. She also discusses the financial consequences of having cancer and her experience with economic abuse. Timestamps 00:00 Introduction 02:41 Understanding the gender wealth gap 06:09 Why women invest less than men 10:41 Practical tips for getting started 15:12 Misogyny in finance and campaigning for change 20:02 The financial impact of cancer 23:12 Economic abuse and financial independence 26:24 MoneyShe and Gina’s current campaigning work Women and Wealth is the monthly podcast series from Investors’ Chronicle. You can listen to and watch the episodes alongside our other podcasts on Acast , Apple , Spotify or YouTube . If you have any questions you’d like Val to answer in the podcast, email val.cipriani@ft.com Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times . Hosted on Acast. See acast.com/privacy for more information.

  ListenShow Notes
• 

  Investors' Chronicle

  The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show

  Aug 6, 202638 min

  M&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US rival Bristol Myers Squibb. Julian Hofmann discusses the merits of the mooted $400bn deal, the drawbacks and why investors’ response to the rumour has been bleak.  We then turn to what could be the greatest disrupter humans have seen for decades: the rise of AI and what it means for the jobs market. As speculation runs rampant as to how many roles could be lost, Hugh Moorhead is in the studio to curb some of those concerns. Hugh explains what’s actually going on, which companies might stand to benefit, which might not, and how investors should respond. Finally, Mark Robinson puts medical device maker Smith & Nephew under the microscope after its half-year figures suggest its long-awaited rebound hasn’t quite arrived. But with an activist lurking on the shareholder register, could better times be on the way? Timestamps 00:00 Introduction 1:20 AstraZeneca 15:43 AI's impact on the jobs market and what this means for investors 30:23 Smith & Nephew Listen to more podcasts from Investors’ Chronicle on Apple , Spotify and YouTube Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times . Hosted on Acast. See acast.com/privacy for more information.

  ListenShow Notes
• 

  Investors' Chronicle

  US IPOs, Rentokil and emerging markets: Companies and Markets show

  Jul 30, 202630 min

  Results season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards, and this week’s show dives into one of the FTSE 100’s biggest fallers, Rentokil. The pest control business’s shares plunged after its half-year figures. Julian Hofmann explains why. Then, we look overseas, with many of the big AI and semiconductor trades going into reverse over recent weeks, including memory-chip makers SK Hynix and Samsung. So what better time to discuss how to pick out the value shares in these global markets. Michael Fahy talks through his favourites .  And finally, we look at the consequences of the SpaceX IPO for Britain’s investors – not the losses on which they’re sitting, but the possibility of it having tipped the first domino on access to US IPOs. Helen Kirrane explains what’s going on Timestamps 00:00  Introduction 00:57 Rentokil 10:54 Global value hunting 22:33  US IPOs Listen to more podcasts from Investors’ Chronicle on Apple , Spotify and YouTube Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times . Hosted on Acast. See acast.com/privacy for more information.

  ListenShow Notes
• 

  Investors' Chronicle

  ‘We are the space 3i’: Mark Boggett of Seraphim Space

  Jul 27, 202644 min

  Seraphim Space (SSIT) has been one of the best performing investment trusts in the past year. Helped by the enthusiasm for the sector generated by SpaceX, the £400mn trust pulled off a rare fundraising and now has a pile of cash to deploy. Val Cipriani sits down with chief executive Mark Boggett, who discusses opportunities and volatility in space, why he isn’t afraid of concentration, and how space technology could prove as revolutionary as the internet or AI. You can listen to the interview, alongside all of our other podcasts, on Acast, Apple, Spotify or YouTube. Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times . Hosted on Acast. See acast.com/privacy for more information.

  ListenShow Notes

Recent guests on Investors' Chronicle. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.